---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-25-000257"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2025-09-16T23:59:59+00:00"
generated_at: "2026-05-17T06:26:39.506043+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# DexCom CEO Kevin Sayer takes temporary medical leave; Jacob Leach appointed interim CEO

## Summary
- Kevin R. Sayer, CEO and Chairman, takes temporary medical leave effective Sept 14, 2025.
- Jacob S. Leach, President and COO, appointed interim principal executive officer.
- Mark Foletta, Lead Independent Director, appointed interim chairman of the Board.
- No additional compensation for interim appointments.

## SEC filing metadata
- accession: 0001093557-25-000257
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2025-09-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000257/0001093557-25-000257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355725000257/dxcm-20250914.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-25-000257
- JSON: https://secwatch.observer/filing/0001093557-25-000257.json
- Plain text: https://secwatch.observer/filing/0001093557-25-000257.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.